Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Tobias Rutger Simpson has worked on the following 84 EPO patent applications which have been published in the last five years:

EP11766762

SELECTION AND USE OF HOST CELLS FOR PRODUCTION OF GLYCOPROTEINS

IPC classification:
A61K 45/00, C07K 1/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11740764

C-MET MODULATOR PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 9/20, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11764655

DUAL INHIBITORS OF MET AND VEGF FOR THE TREATMENT OF CASTRATION- RESISTANT PROSTATE CANCER AND OSTEOBLASTIC BONE METASTASES

IPC classification:
A61K 31/00, A61K 31/47, A61P 35/00, A61P 35/04
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12704492

PROCESSES FOR PREPARING QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS

IPC classification:
A61K 31/47, A61P 35/00, C07D 215/227
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13151945

c-Met modulators and methods of use

IPC classification:
A61K 31/47, A61K 31/4709, A61K 31/517, A61P 35/00, C07D 215/22
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12720754

METHOD OF TREATING CANCER AND BONE CANCER PAIN

IPC classification:
A61K 31/47, A61P 35/00
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12790362

MODIFIED GLYCOPROTEINS

IPC classification:
C07K 16/00, C12P 21/08
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12730609

DETECTION OF MEMBRANE PROTEIN-THERAPEUTIC AGENT COMPLEXES BY MASS SPECTROMETRY

IPC classification:
B01D 15/38, G01N 33/68, G01N 33/94
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13163216

Heterocyclic aspartyl protease inhibitors

IPC classification:
A61K 31/513, A61P 25/28, C07D 239/20, C07D 401/04, C07D 401/10, C07D 403/04, C07D 405/04, C07D 409/14, C07D 411/04, C07D 417/04, C07D 417/14, C07D 495/20
Applicant:
Merck & Co. Inc.
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP12758591

DEVICE, METHOD AND APPARATUS FOR THE TRANSFER OF ANALYTES

IPC classification:
G01N 30/04, G01N 33/00, G01N 35/10
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12757511

TREATMENT OF CANCER

IPC classification:
A01N 43/04, A61K 31/44, A61K 31/4745, A61K 45/06, A61P 35/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12770368

METHOD FOR TREATING OSTEOPOROSIS

IPC classification:
A61K 31/47, A61P 19/10
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP13179424

Tosylate Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor

IPC classification:
A61K 31/435, A61K 31/438, A61K 31/495, A61P 1/08, C07D 471/10
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12775050

ASYMMETRIC SYNTHESIS OF ORGANIC COMPOUNDS

IPC classification:
C07B 53/00, C07C 45/69, C07C 49/403, C07C 49/413, C07C 49/463
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12783763

PROCESS FOR PREPARING QUINOLINE DERIVATIVES

IPC classification:
C07C 231/02, C07C 233/59, C07D 215/22, C07D 413/12
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12753313

TREATMENTS FOR GASTROINTESTINAL DISORDERS

IPC classification:
A61K 38/10, C07K 7/54
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
PATENT GRANTED
EP12787328

DUAL INHIBITOR OF MET AND VEGF FOR TREATING CANCER

IPC classification:
A61K 31/47, A61K 31/517, A61K 35/04, A61P 35/00
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13736214

NUCLEOTIDE CLONING METHODS

IPC classification:
C12N 15/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13743255

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

IPC classification:
C08B 37/16
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13743529

POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE

IPC classification:
A61K 9/00, A61K 47/48, A61P 35/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13743111

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

IPC classification:
A61K 31/715, C08B 37/16
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11758343

TREATMENT OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME

IPC classification:
A61K 38/10, A61P 1/00, A61P 43/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13714993

PROCESS FOR PRODUCING TWO-DIMENSIONAL NANOMATERIALS

IPC classification:
B82Y 40/00, C01B 31/04, C23C 16/26, C30B 25/16, C30B 25/18, C30B 29/02
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13751423

CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

IPC classification:
A61K 48/00, C08F 290/14, C12N 5/00, C12N 15/11
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13724470

COATED MEDICAL DEVICES COMPRISING A WATER - INSOLUBLE THERAPEUTIC AGENT AND AN ADDITIVE

IPC classification:
A61F 2/915, A61F 2/958, A61K 9/00, A61K 31/337, A61K 31/715, A61K 31/727, A61M 25/10
Applicant:
Cook Medical Technologies LLC
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13781339

MODIFIED GLYCOPROTEINS

IPC classification:
A61K 39/395, C07K 16/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13722238

A DUAL MET - VEGF MODULATOR FOR TREATING OSTEOLYTIC BONE METASTASES

IPC classification:
A61K 31/47, A61P 35/04
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14184656

Anti-tumor macrophage m1 morphology inducer

IPC classification:
A61L 31/16
Applicant:
Cook Medical Technologies LLC
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13807428

MESOPOROUS OXIDE NANOPARTICLES AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 9/14, A61K 9/16, A61K 47/02, A61K 47/30
Applicant:
Cornell University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13765886

INHIBITORS OF MET, VEGFR AND RET FOR USE IN THE TREATMENT OF LUNG ADENOCARCINOMA

IPC classification:
A61K 31/47, A61P 35/00
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13843562

TREATMENT OF CANCER

IPC classification:
A61K 31/724, A61K 39/395, A61P 35/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13858461

METHODS OF MODULATING FOLLICLE STIMULATING HORMONE ACTIVITY

IPC classification:
A61K 45/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13865112

COMPOSITIONS AND METHOD FOR LIGHT TRIGGERED RELEASE OF MATERIALS FROM NANOVESICLES

IPC classification:
A61B 5/00, C07D 487/22
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13821708

DETECTION OF MEMBRANE PROTEINS

IPC classification:
G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14746208

AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF

IPC classification:
A01N 43/42, A61K 31/44
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14746563

METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE

IPC classification:
A61K 31/517
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14769180

METHODS OF CELL CULTURE

IPC classification:
A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14776142

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/02, C12P 1/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14721149

METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE

IPC classification:
A61K 31/47, A61P 35/00, C07C 233/60, C07C 305/24, C07D 215/22
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14775649

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/07, C12P 21/04
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14775563

ENHANCEMENT OF VACCINES

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/02
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14770567

ION-CONDUCTING BATTERIES WITH SOLID STATE ELECTROLYTE MATERIALS

IPC classification:
H01M 6/18, H01M 8/10, H01M 8/24
Applicant:
University of Maryland College Park
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14724909

CABOZANTINIB DOSAGE FORM AND USE IN THE TREATMENT OF CANCER

IPC classification:
A61K 31/47, A61P 35/00
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15179160

ENCAPSULATED DRUG COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/353, A61L 27/34, A61L 27/54, A61L 29/08, A61L 29/16, A61L 31/10, A61L 31/16
Applicant:
Cook Medical Technologies LLC
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15179148

COMPOSITIONS AND DEVICES INCORPORATING WATER-INSOLUBLE THERAPEUTIC AGENTS AND METHODS OF THE USE THEREOF

IPC classification:
A61K 31/353, A61L 27/34, A61L 27/44, A61L 27/54, A61L 29/08, A61L 29/16, A61L 31/10, A61L 31/16
Applicant:
Cook Medical Technologies LLC
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14770577

CITRATE CONTAINING BEVERAGE

IPC classification:
A23L 2/385, A23L 2/52, A61K 31/19, A61P 3/02, A61P 3/14
Applicant:
New York University
Applicant:
The Regents of the University of California
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14724594

DRUG COMBINATIONS TO TREAT CANCER

IPC classification:
A61K 9/00, A61K 31/47, A61K 31/517, A61K 31/575, A61K 31/58, A61P 35/00
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14794026

USE OF LAPPAOL F TO INHIBIT TUMOR CELL GROWTH

IPC classification:
A61K 31/015
Applicant:
Guangzhou University of Chinese Medicine
Applicant:
The Research Foundation for the State University of New York - Suny Upstate Medical University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14798473

METHODS FOR THE TREATMENT OF NEURODEGENERATION

IPC classification:
A61P 25/28
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14804677

POLYSACCHARIDE COMPOSITIONS AND RELATED METHODS

IPC classification:
A61K 31/727, C08B 37/10, C08L 5/10
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14803492

PHARMACEUTICAL COMPOSITIONS COMPRISING PYROPHOSPHATE

IPC classification:
A61K 39/395, A61K 47/42, C01B 25/42
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14805110

PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 31/727, C08B 37/10, C08L 5/10
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP11769624

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT AND PREVENTION OF DISORDERS ASSOCIATED WITH PROGENITOR CELL MOBILIZATION

IPC classification:
A61K 31/727, A61K 39/395, A61K 45/06, A61P 35/00, A61P 35/04, C08B 37/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11784186

COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES

IPC classification:
A61K 47/00, A61K 47/48, A61P 29/00, A61P 37/00, C08B 37/16
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14791856

RECHARGEABLE POWER SOURCE FOR MOBILE DEVICES WHICH INCLUDES AN ULTRACAPACITOR

IPC classification:
H01G 11/22, H01G 11/36
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14823331

LINE IMMUNOASSAY TESTING DEVICE

IPC classification:
G01N 35/04
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14766283

BIOACTIVE COMPOSITIONS DERIVABLE FROM PLATELET CONCENTRATES, AND METHODS FOR PREPARING AND USING SAME

IPC classification:
A61K 35/14, A61K 38/18, C12N 5/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14863671

CORE-SHELL NANOPARTICLES, METHODS OF MAKING SAME, AND USES OF SAME

IPC classification:
B82Y 30/00, C01F 17/00
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14843496

MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 49/12
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14848904

COMPOSITIONS AND METHODS FOR REDUCING ANTIGEN-SPECIFIC IMMUNOGENICITY

IPC classification:
A61K 39/00, C07F 9/09
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14849624

TREATMENT OF CANCER

IPC classification:
A61K 31/404
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14847723

SYSTEM AND METHOD FOR REMOVING TRANSITION METALS FROM SOLUTION

IPC classification:
C22B 3/00
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11766759

METHOD FOR QUANTIFYING HIGH MANNOSE CONTAINING GLYCOFORMS

IPC classification:
C12P 21/00, C12Q 1/34, G01N 33/68
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11713509

ALUMINA-BASED CERAMIC MATERIALS AND PROCESS FOR THE PRODUCTION THEREOF

IPC classification:
C04B 35/111
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11794888

SUSTAINABLE PACKAGING FOR CONSUMER PRODUCTS

IPC classification:
B65D 1/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Multiple attorneys, Procter & Gamble Service GmbH
Status:
PATENT GRANTED
EP16704085

GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF

IPC classification:
A61K 45/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15162515

DIESEL EXHAUST FLUID SOLUTIONS AND METHODS OF USING THE SAME

IPC classification:
B01D 53/90, B01D 53/94, C07C 69/40
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16165628

MONOLAYER FILMS OF SEMICONDUCTING METAL DICHALCOGENIDES, METHODS OF MAKING SAME, AND USES OF SAME

IPC classification:
H01L 21/02
Applicant:
Cornell University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14870517

VENTILATION DEVICES AND METHODS

IPC classification:
B65D 90/34
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14824655

DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 9/48, A61K 9/50, A61K 38/10
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14875542

BENZAMIDE AND NICOTINAMIDE COMPOUNDS AND METHODS OF USING SAME

IPC classification:
A61K 31/166, A61K 31/4155, C07C 237/22
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15752637

COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA

IPC classification:
A61K 31/435
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15714340

DOSING OF CABOZANTINIB FORMULATIONS

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/48, A61K 31/47, A61P 35/00, C07C 233/60, C07C 305/24, C07D 215/22
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15710315

CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PHENYL}-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1, 1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE

IPC classification:
A61K 31/47, A61P 35/00, C07D 215/22
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15712504

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

IPC classification:
A61K 35/12, A61K 39/00, C12N 5/07
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15780722

COMPOSITE NANOMATERIALS AND MICROMATERIALS, FILMS OF SAME, AND METHODS OF MAKING AND USES OF SAME

IPC classification:
C01G 31/02
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15721100

METHOD OF TREATING LUNG ADENOCARCINOMA

IPC classification:
A61K 31/337, A61K 31/47, A61K 31/517, A61K 31/7068, A61P 35/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15716568

PROCESS FOR THE PRODUCTION OF TWO-DIMENSIONAL NANOMATERIALS

IPC classification:
C23C 16/00, C23C 16/26, C23C 16/34, C01B 32/182
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15815151

SURFACTANT-STRIPPED MICELLE COMPOSITIONS WITH HIGH CARGO TO SURFACTANT RATIO

IPC classification:
A61K 9/107
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15821872

USE OF HYALURONIDASE FOR TREATMENT OF MUSCLE STIFFNESS

IPC classification:
A61K 38/47
Applicant:
New York University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15750223

DRUG COMBINATIONS TO TREAT MULTIPLE MYELOMA

IPC classification:
A61K 31/194, A61K 31/47, A61K 31/4965, A61K 31/69, A61K 38/05
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15841872

IDENTIFYING STATUS OF MALE FERTILITY BY DETERMINING SPERM CAPACITATION

IPC classification:
C07K 2/00
Applicant:
Cornell University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
Request for examination was made
EP15835382

VO2 AND V2O5 NANO-AND MICRO-MATERIALS AND PROCESSES OF MAKING AND USES OF SAME

IPC classification:
C01G 31/02
Applicant:
The Research Foundation for the State University of New York University at Buffalo - Office Of Science Technology Transfer And Economic Outreach
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature